We serve Chemical Name:3,5-dibromo-1H-1,2,4-triazole CAS:7411-23-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,5-dibromo-1H-1,2,4-triazole
CAS.NO:7411-23-6
Synonyms:3,5-dibromo-1H-1,2,4-triazole;1H-1,2,4-Triazole, 3,5-dibromo-;MFCD00487260
Molecular Formula:C2HBr2N3
Molecular Weight:226.857
HS Code:2933990090
Physical and Chemical Properties:
Melting point:201ºC
Boiling point:364.8±25.0 °C at 760 mmHg
Density:2.6±0.1 g/cm3
Index of Refraction:1.668
PSA:41.57000
Exact Mass:224.853714
LogP:2.24
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3,5-dibromo-1H-1,2,4-triazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00487260 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-1,2,4-Triazole, 3,5-dibromo- Use and application,MFCD00487260 technical grade,usp/ep/jp grade.
Related News: At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. 3,5-dibromo-1H-1,2,4-triazole manufacturer If the results from that trial are positive, the company might apply to the U.S. Food and Drug Administration for the same accelerated approval pathway recently used to bring the controversial Alzheimer’s drug aducanumab to market, Novak said. 3,5-dibromo-1H-1,2,4-triazole supplier At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. 3,5-dibromo-1H-1,2,4-triazole vendor Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs. 3,5-dibromo-1H-1,2,4-triazole factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
